INMD News and Press, InMode Ltd. From 11/10/22

The stock of aesthetic surgical company InMode (NASDAQ: INMD) has fallen 66% from its high, underperforming the broader market over the past year. Investors are scratching their heads and wondering whether the market knows better or if there's a colossal misunderstanding here. B...

Summary INMD has an expanding product portfolio and operational footprint, which translates to a growing top line. It maintains a healthy balance sheet that can fund possible M&A activity as well as its current repurchase program. The management provided a strong outlook a...

InMode to Present at Upcoming Investor Conferences Before the End of 2022 PR Newswire YOKNEAM, Israel , Nov. 1, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode ...

InMode Ltd. (INMD) Q3 2022 Results Conference Call October 27, 2022 08:30 AM ET Company Participants Miri Segal - Investor Relations, MS-IR LLC Moshe Mizrahy - Chairman and Chief Executive Officer Michael Kreindel - Chief Technology Officer & Director Yai...

InMode ( NASDAQ: INMD ) is trading 5% higher after the company posted better-than-expected result and forecast 2022 revenue, profit above estimates, helped by increase in its minimally invasive and subdermal ablative treatments. Q3 Non-GAAP EPS of $0.66 beats b...

InMode press release ( NASDAQ: INMD ): Q3 Non-GAAP EPS of $0.66 beats by $0.08 . Revenue of $121.2M (+28.7% Y/Y) beats by $5.11M . Non-GAAP gross margin for the third quarter of 2022 was 85% and 86% for the third quarter of 2021. Non-GAAP operating margin f...

InMode Reports Third Quarter 2022 Financial Results; Record Quarterly Revenue of $121.2 M, Represents 29% Year-Over-Year Growth PR Newswire YOKNEAM, Israel , Oct. 27, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode") , a leading global provider o...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips I know that saying “This time could be different” is dangerous. But still, when it comes to U.S. stocks, I believe that this time could be different and that the long-awaited (by me, at least) bull market may...

Summary InMode issued a robust Q3 preliminary earnings release that led to a momentum surge last week. However, the gains were mostly lost by the end of the week. The market renewed its concerns with global macroeconomic headwinds, worsened by the Fed's aggressive rate hikes to co...

Shares of InMode (NASDAQ: INMD) soared on Thursday after the medical device company released preliminary financial results for the third quarter of 2022. The numbers were better than Wall Street anticipated. As a result, InMode stock was up 13% as of 11:45 a.m. ET. InMode habitu...